Keel Point, LLC Novartis Ag Transaction History

Keel Point, LLC

$1.61 Billion
Q3 2025

A detailed history of Keel Point, LLC transactions in Novartis Ag stock. As of the latest transaction made, Keel Point, LLC holds 8,079 shares of NVS stock, worth $1.06 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

8,079

Previous 7,746 4.3%

Holding current value

$1.06 Million

Previous $937,000 10.57%

% of portfolio

0.06%

Previous 0.06%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Dec 16, 2025	BUY	$113.5 - $129.73 $37,795 - $43,200	333 Added 4.3%	8,079 $1.04 Million
Q2 2025 Aug 14, 2025	BUY	$101.96 - $121.01 $88,909 - $105,520	872 Added 12.69%	7,746 $937,000
Q1 2025 May 15, 2025	BUY	$97.14 - $115.57 $17,776 - $21,149	183 Added 2.74%	6,874 $766,000
Q4 2024 Feb 14, 2025	SELL	$96.78 - $117.18 $82,843 - $100,306	-856 Reduced 11.34%	6,691 $651,000
Q3 2024 Nov 14, 2024	SELL	$106.13 - $120.89 $19,952 - $22,727	-188 Reduced 2.43%	7,547 $868,000

Q2 2024 Aug 14, 2024	BUY	$92.57 - $107.37 $390,737 - $453,208	4,221 Added 120.12%	7,735 $823,000
Q1 2024 Apr 16, 2024	BUY	$95.27 - $108.47 $82,694 - $94,151	868 Added 32.8%	3,514 $339,000
Q4 2023 Jan 30, 2024	BUY	$92.27 - $101.54 $6,735 - $7,412	73 Added 2.84%	2,646 $267,000
Q3 2023 Oct 26, 2023	SELL	$94.73 - $105.13 $10,420 - $11,564	-110 Reduced 4.1%	2,573 $262,000
Q2 2023 Jul 12, 2023	BUY	$92.52 - $104.91 $4,070 - $4,616	44 Added 1.67%	2,683 $270,000
Q1 2023 Apr 03, 2023	SELL	$80.03 - $92.81 $28,570 - $33,133	-357 Reduced 11.92%	2,639 $242,000
Q4 2022 Jan 17, 2023	BUY	$75.55 - $92.52 $15,941 - $19,521	211 Added 7.58%	2,996 $0
Q3 2022 Oct 05, 2022	SELL	$74.61 - $87.26 $5,744 - $6,719	-77 Reduced 2.69%	2,785 $212,000
Q2 2022 Aug 11, 2022	BUY	$80.52 - $93.75 $10,548 - $12,281	131 Added 4.8%	2,862 $250,000
Q1 2022 Apr 27, 2022	SELL	$80.11 - $90.62 $14,179 - $16,039	-177 Reduced 6.09%	2,731 $240,000
Q4 2021 Jan 31, 2022	SELL	$79.7 - $88.13 $47,899 - $52,966	-601 Reduced 17.13%	2,908 $254,000
Q3 2021 Nov 04, 2021	BUY	$81.78 - $95.14 $280,832 - $326,710	3,434 Added 4578.67%	3,509 $287,000
Q2 2021 Aug 06, 2021	SELL	$85.24 - $94.15 $288,707 - $318,886	-3,387 Reduced 97.83%	75 $317,000
Q2 2021 Aug 06, 2021	SELL	$85.24 - $94.15 $26,083 - $28,809	-306 Reduced 8.12%	3,462 $316,000
Q1 2021 May 17, 2021	BUY	$83.5 - $98.47 $314,628 - $371,034	3,768 New	3,768 $322,000

Others Institutions Holding NVS

# of Institutions

1,599

Shares Held

137M

Call Options Held

1.53M

Put Options Held

2.22M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $283B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keel Point, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keel Point, LLC with notifications on news.

Account